These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38368039)

  • 61. Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ
    Circ J; 2010 Nov; 74(11):2271-82. PubMed ID: 20962423
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy.
    Norrish G; Cleary A; Field E; Cervi E; Boleti O; Ziółkowska L; Olivotto I; Khraiche D; Limongelli G; Anastasakis A; Weintraub R; Biagini E; Ragni L; Prendiville T; Duignan S; McLeod K; Ilina M; Fernandez A; Marrone C; Bökenkamp R; Baban A; Kubus P; Daubeney PEF; Sarquella-Brugada G; Cesar S; Klaassen S; Ojala TH; Bhole V; Medrano C; Uzun O; Brown E; Gran F; Sinagra G; Castro FJ; Stuart G; Yamazawa H; Barriales-Villa R; Garcia-Guereta L; Adwani S; Linter K; Bharucha T; Gonzales-Lopez E; Siles A; Rasmussen TB; Calcagnino M; Jones CB; De Wilde H; Kubo T; Felice T; Popoiu A; Mogensen J; Mathur S; Centeno F; Reinhardt Z; Schouvey S; Elliott PM; Kaski JP
    J Am Coll Cardiol; 2022 May; 79(20):1986-1997. PubMed ID: 35589160
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [New strategies for assessing the risk of sudden cardiac death in hypertrophic cardiomyopathy].
    Jaworski K; Możeńska O; Kosior DA
    Pol Merkur Lekarski; 2016 Aug; 41(242):65-9. PubMed ID: 27591441
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy.
    He CJ; Zhu CY; Fan HY; Qian YZ; Zhai CL; Hu HL
    Clin Cardiol; 2023 Dec; 46(12):1569-1577. PubMed ID: 37711064
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hypertrophic Cardiomyopathy: Is a 'Cure' Coming . . . Or Is It Already Here?
    Maron BJ; Rowin EJ; Maron MS
    Am J Med; 2020 Aug; 133(8):886-888. PubMed ID: 32741446
    [No Abstract]   [Full Text] [Related]  

  • 66. Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation.
    Zampieri M; Salvi S; Fumagalli C; Argirò A; Zocchi C; Del Franco A; Iannaccone G; Giovani S; Ferrantini C; Palinkas ED; Cappelli F; Olivotto I
    Int J Cardiol; 2023 Mar; 374():65-72. PubMed ID: 36621577
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic Implication of First-Degree Atrioventricular Block in Patients With Hypertrophic Cardiomyopathy.
    Higuchi S; Minami Y; Shoda M; Shirotani S; Saito C; Haruki S; Gotou M; Yagishita D; Ejima K; Hagiwara N
    J Am Heart Assoc; 2020 Mar; 9(6):e015064. PubMed ID: 32146896
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
    Lafreniere-Roula M; Bolkier Y; Zahavich L; Mathew J; George K; Wilson J; Stephenson EA; Benson LN; Manlhiot C; Mital S
    Eur Heart J; 2019 Dec; 40(45):3672-3681. PubMed ID: 31170284
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ventricular Septal Myectomy Decreases Long-Term Risk for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
    Rowin EJ; Cooper C; Carrick RT; Tsoi M; Maron BJ; Maron MS
    Am J Cardiol; 2022 Sep; 179():70-73. PubMed ID: 35835601
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hypertrophic cardiomyopathy considerations for the managed care pharmacist.
    Taddei-Allen P
    Am J Manag Care; 2021 Apr; 27(6 Suppl):S118-S125. PubMed ID: 33861536
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hypertrophic cardiomyopathy in children.
    Wang S; Zhu C
    Asian Cardiovasc Thorac Ann; 2022 Jan; 30(1):92-97. PubMed ID: 34569255
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
    Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
    J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Medical therapies for hypertrophic cardiomyopathy: Current state of the art.
    Desai MY; Owens A; Wang A
    Prog Cardiovasc Dis; 2023; 80():32-37. PubMed ID: 37619712
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Current perspectives of sudden cardiac death management in hypertrophic cardiomyopathy.
    Pu L; Li J; Qi W; Zhang J; Chen H; Tang Z; Han Y; Wang J; Chen Y
    Heart Fail Rev; 2024 Mar; 29(2):395-404. PubMed ID: 37865929
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery.
    Magnusson P; Gadler F; Liv P; Mörner S
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1088-94. PubMed ID: 26178879
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Utilization and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Hypertrophic Cardiomyopathy.
    Goldstein SA; Kennedy KF; Friedman DJ; Al-Khatib SM; Wang A
    J Am Heart Assoc; 2023 Aug; 12(16):e029293. PubMed ID: 37586066
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.
    Rowin EJ; Maron BJ; Haas TS; Garberich RF; Wang W; Link MS; Maron MS
    J Am Coll Cardiol; 2017 Feb; 69(7):761-773. PubMed ID: 28209216
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: a retrospective cohort study.
    Wang Y; Gao W; Han X; Jiang J; Sandler B; Li X; Zema C
    J Med Econ; 2023; 26(1):1495-1506. PubMed ID: 37902966
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical and genetic characterization of patients with hypertrophic cardiomyopathy and right atrial enlargement.
    Limongelli G; Masarone D; Frisso G; Iacomino M; Ferrara I; Rea A; Gravino R; Bossone E; Salvatore F; Calabro R; Elliott P; Pacileo G
    J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):249-254. PubMed ID: 26808413
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators.
    Magnusson P; Mörner S; Gadler F; Karlsson J
    Health Qual Life Outcomes; 2016 Apr; 14():62. PubMed ID: 27079917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.